AXA Diagnostics Highlights SkyLAB752 System
By LabMedica International staff writers Posted on 05 Feb 2018 |

The SkyLAB752 system (Photo courtesy of AXA Diagnostics).
AXA Diagnostics (Milan, Italy) participated in MEDLAB Middle East, the world’s largest attended laboratory & IVD exhibition and conference, held from February 5-8, 2018 in Dubai, UAE. AXA Diagnostics shared the booth with its sister company, Sclavo Diagnostics Int., where it provided all updates and new applications of its SkyLAB752 automated ELISA/IFA processor. Sclavo is a leading manufacturer of reagents for clinical chemistry, specific/urinary proteins, coagulation, and serology.
AXA Diagnostics is a partner to DASIT Group, which also comprises other leading IVD organizations, such as DASIT S.p.A. and industrial and research laboratories, such as CARLO ERBA Reagents S.r.l. and FASTER S.r.l. AXA Diagnostics develops, produces and markets IVD reagents dedicated to autoimmunity disease and instruments for the automation of all ELISA and IFA testing. The company also provides OEM equipment to fulfill the needs of automating the processing of IVD reagents.
The SkyLAB752 automated ELISA/IFA processor from AXA Diagnostics can simultaneously process ELISA microplates and IFA slides. The system is equipped with two innovative dispensing systems able to work simultaneously and independently. This enables the instrument to pipette an entire microplate in half the time compared to other analyzers available on the market. The movement of the manifold robotic arm does not interfere with the movement of the other two robotic arms, pipettes and microplate robotic arm, making the dispensing, washing and reading steps independent of each other. This architecture allows to maintain the execution times of each processing step aligned with the directions provided on the kit's IFU, leading to elimination of any drift effect.
Its innovative design allows constant access to the microplates by the washer and pipettes, even during incubation, so that the whole procedure applied to each strip can be closely followed and monitored. The SkyLAB 752 uses a LED microplate reading system that allows precision, reduced maintenance and a 3.3 OD photometric range. A state of the art LED light-source provides high performance and minimum maintenance, large measurement range and excellent reproducibility.
The system accommodates five positions on the working area equipped with incubators. Under the working area, two additional positions are available, one of them equipped with a shaker incubator. Each of the seven positions can contain both microplates and IFA slides. As an optional under the working area, SkyLAB 752 can accommodate from one to four positions equipped with incubators and shakers that can contain both microplates and IFA slides.
Latest MEDLAB 2018 News
- Snibe Diagnostic Displays Analyzers at MEDLAB Europe 2018
- MEDLAB Europe 2018 Presents Latest Technologies and Developments
- MedLab Middle East Continues as World's Largest Attended Laboratory Exhibition and Conference
- Fujifilm Showcases DRI-CHEM NX700 Dry Chemistry Analyzer
- Zeesan Biotech Displays DNA Automated Extraction System
- Priorclave Highlights Its Smallest Steam Sterilizer
- HORIBA Medical Launches HELO and Yumizen G Range
- Astell Scientific Showcases Latest Autoclave Range
- Block Scientific Showcases Medical Lab Equipment Devices
- BIOBASE Displays Range Of Laboratory & Medical Analyzers
- EKF Diagnostics Showcases Latest Data Management Solutions
- Siemens Healthineers Showcases Advanced Diagnostics Analyzers
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Blood Test Could Predict Relapse of Autoimmune Blood Vessel Disease
Neutrophils, once believed to be uniform in nature, have been discovered to exhibit significant diversity. These immune cells, which play a crucial role in fighting infections, are also implicated in autoimmune... Read more
First-of-its-Kind Blood Test Detects Trauma-Related Diseases
In today’s fast-paced world, stress and trauma have unfortunately become common experiences for many individuals. Continuous exposure to stress hormones can confuse the immune system, causing it to misinterpret... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more